FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
A pharma industry veteran with over three decades of experience in domestic as well as international markets
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
Subscribe To Our Newsletter & Stay Updated
